A purported binding agent of filamin A
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PTI-125 (hydrochloride)

Item No. 41859

Technical Information
Formal Name
8-methyl-1-(phenylmethyl)-1,4,8-triazaspiro[4.5]decan-2-one, dihydrochloride
CAS Number
2480226-06-8
Molecular Formula
C15H21N3O • 2HCl
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/mlPBS (pH 7.2): Soluble: ≥10 mg/ml
SMILES
CN1CCC(NCC2=O)(N2CC3=CC=CC=C3)CC1.Cl.Cl
InChi Code
InChI=1S/C15H21N3O.2ClH/c1-17-9-7-15(8-10-17)16-11-14(19)18(15)12-13-5-3-2-4-6-13;;/h2-6,16H,7-12H2,1H3;2*1H
InChi Key
IZIPGYSLPYPJDQ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    PTI-125 is a purported binding agent of filamin A, a cytoskeletal protein said to stabilize the interaction between amyloid-β (1-42) (Aβ42) and the α7 nicotinic acetylcholine receptor (nAChR).1,2 PTI-125 reportedly binds to filamin A to reverse an aberrant conformational change induced by Aβ42, which prevents and reverses Aβ42-α7 nAChR binding and improves neuropathological outcomes in the 3xTg mouse model of Alzheimer’s disease. However, the data regarding PTI-125 have prompted expressions of concern by the journals in which the data were published.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1.  Expression of concern: Wang et al., "Reducing amyloid-related alzheimer’s disease pathogenesis by a small molecule targeting filamin A". J. Neurosci. 42(3), 529 (2022).

    2. Wang, H.Y., Lee, K.C., Pei, Z., et alPTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer’s disease pathogenesis. Neurobiol. Aging 55, 99-114 (2017).